DrugPatentWatch Database Preview
Profile for Serbia Patent: 50621
US Patent Family Members and Approved Drugs for Serbia Patent: 50621
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jun 27, 2028 | Takeda Pharms Usa | KAZANO | alogliptin benzoate; metformin hydrochloride |
Start Trial | Jun 27, 2028 | Takeda Pharms Usa | NESINA | alogliptin benzoate |
Start Trial | Jun 27, 2028 | Takeda Pharms Usa | OSENI | alogliptin benzoate; pioglitazone hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |